Aalto Bio Reagents Yellow Fever Monoclonal Antibodies

Aalto Bio Reagents announced the availability of its yellow fever monoclonal antibodies for diagnostic test manufacturers, vaccine developers, and researchers globally. The monoclonal antibodies are raised against cell-culture derived viral lysate from strain 17D. The yellow fever antibodies complement the firm's portfolio of recombinant proteins and antibodies for chikungunya, dengue, and Zika virus diagnostic tests.